The Effects of Unstable Shoes on Chronic Low Back Pain

February 20, 2012 updated by: Armand Staphane, University Hospital, Geneva

Some physicians, physiotherapists and nurses use or even suggest unstable shoes in cases of low back pain. No studies on the real effects of these shoes on low back pain in health care professions have been carried out and therefore as yet there is no real evidence of their effectiveness. Thus the investigators assume that wearing unstable shoes over a period of six weeks could reduce low back pain and functional disability due to the changes of the gait and posture and may increase the quality of life.

The purposes of this study are:

  1. To evaluate the modifications of pain level, functional capacity and quality of life among individuals with moderate level of non-specific chronic low back pain after wearing unstable shoes.
  2. To quantify biomechanical modifications of gait and posture.

Study Overview

Study Type

Interventional

Enrollment (Actual)

40

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Geneva, Switzerland, 1211
        • University Hospitals of Geneva

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

30 years to 65 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion criteria:

  • employees of Geneva University Hospital
  • working in a standing position for at least 50% of their working day
  • aged between 30 and 65
  • having chronic low back pain that has been defined at least 3 out of 10 on a visual analogue scale during the last 3 months or the need to take regular pain medication for this reason

Exclusion criteria:

  • having severe pain in other body parts
  • undergone back surgery, neurological or balance problems
  • inability to walk a distance of 100 meters
  • already worn unstable shoes and being off of work because of low back pain

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Unstable shoes (MBT)
MBT shoes (Masai Barefoot Technology, Switzerland)
Wearing unstable (MBT) shoes during 6 weeks
Sham Comparator: Stable shoes (Adidas)
Adidas stable shoes (Adidas Bigroar2)
Normal stable shoes (Adidas Bigroar2)

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change from baseline in low back pain at 6 weeks
Time Frame: Baseline and 6 weeks
Low back pain level with the visual analogue scale (VAS) from 0 to 10;
Baseline and 6 weeks
Change from baseline in the Roland-Morris disability questionnaire at 6 weeks
Time Frame: Baseline and 6 weeks
functional disability with the Roland-Morris disability questionnaire (this questionnaire has been validated in French as the Functional Disability Scale for the Assessment of Low Back Pain - Eifel)
Baseline and 6 weeks
Change from baseline in the EQ-5D quality of life questionnaire at 6 weeks
Time Frame: Baseline and 6 weeks
Quality of life with the EQ-5D.
Baseline and 6 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change from baseline in gait speed at 6 weeks
Time Frame: Baseline and 6 weeks
Seft-selected gait speed
Baseline and 6 weeks
Change from baseline in balance performance at 6 weeks
Time Frame: Baseline and 6 weeks

center of pressure speed in conditions :

  • eyes opened and eyes closed
  • stable and unstable surface
Baseline and 6 weeks
Change from baseline in ankle dorsiflexion during gait at 6 weeks
Time Frame: Baseline and 6 weeks
Ankle dorsiflexion at initial contact during gait
Baseline and 6 weeks
Change from baseline in pelvis anteversion during gait at 6 weeks
Time Frame: Baseline and 6 weeks
Mean pelvis anteversion during gait
Baseline and 6 weeks
Change from baseline in trunk anteversion during gait at 6 weeks
Time Frame: Baseline and 6 weeks
Mean trunk anteversion during gait
Baseline and 6 weeks
Change from baseline in activation period of lower-limb muscles during gait at 6 weeks
Time Frame: Baseline and 6 weeks
Activation period of lower-limb muscles (gasctrocnemius, peroneus, tibialis anterior, rectus femoris and semi-tendinosus) during gait
Baseline and 6 weeks
Change from baseline in activation period of erector spinae during gait at 6 weeks
Time Frame: Baseline and 6 weeks
Activation period of erector spinae during gait
Baseline and 6 weeks
Change from baseline in maximum knee extension during gait stance phase at 6 weeks
Time Frame: Baseline and 6 weeks
Maximum knee extension during stance phase
Baseline and 6 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

January 1, 2011

Primary Completion (Actual)

September 1, 2011

Study Completion (Actual)

November 1, 2011

Study Registration Dates

First Submitted

June 15, 2011

First Submitted That Met QC Criteria

June 27, 2011

First Posted (Estimate)

June 28, 2011

Study Record Updates

Last Update Posted (Estimate)

February 22, 2012

Last Update Submitted That Met QC Criteria

February 20, 2012

Last Verified

February 1, 2012

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • LBP-2011

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Low Back Pain

Clinical Trials on Unstable shoes (MBT)

Subscribe